TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases

Academic Article
Publication Date:
2021
abstract:
*
Iris type:
01.01 Articolo in rivista
Keywords:
chronic lymphocytic leukemia cases
List of contributors:
Authors of the University:
Handle:
https://iris.cnr.it/handle/20.500.14243/419809
Published in:
AMERICAN JOURNAL OF HEMATOLOGY (PRINT)
Journal